Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: biotechnology law
Astrazeneca v Apotex – Patent That Label!
I recently had a chance to re-read AstraZeneca LP v. Apotex, Inc., Appeal No. 2009-1381, 1424 (Fed. Cir. Nov. 1, 2010) and realized that it is a virtual case note on how to extend patent term by “patenting the label.” … Continue reading
EMA Draft Guidelines For Biosimilar Antibodies Released
From Dr. Stefan Danner On November 18, 2010, the European Medicines Agency (EMA) released draft versions of two guidelines relating to the regulatory approval of monoclonal antibodies: the “Guideline on biological medicinal products containing monoclonal antibodies”1 and the “Guideline on … Continue reading
Posted in Non-U.S. Practice
Tagged biotechnology law, Dr. Stefan Danner, EMA, intellectual property, Warren Woessner
Leave a comment
Prometheus V. Mayo – Fed. Cir: “We Got It Right The First Time.”
Today, following the vacation and remand of its earlier decision by the Supreme Court post-Bilski, the Federal Circuit again reaffirmed its reversal of the District Court (copy at the end of this post) and held: “The asserted method claims satisfy … Continue reading
Stayin’ Alive – Patent Office Extends “Provisional Application Period.”
On December 8th, the Patent Office announced plans to implement a “Missing Parts Pilot Program” that would permit applicants at the end of the one-year U.S. provisional application term to defer substantive examination for up to 12 months by filing … Continue reading